Alzheimer’s treatment approved in Australia
Kisunla, or Donanemad, by American-based multinational pharmaceutical company Eli Lilly has been approved for use in Australia by the Therapeutic...
Professor Michael Woodward
‘Impactful’ discovery may improve dementia drugs
Australian scientists have made a significant discovery that has the potential to improve the effectiveness of drugs currently used to...